Germany to challenge EU on cannabis?
The German government has performed an abrupt U-turn on recreational cannabis legislation just three months after the new coalition government said such plans were not among its priorities for this year
LATEST ALERTS
-
Japan Ministry of Health considers legalising medical cannabis products… - Europe New rules to protect EU consumers come into force tomorrow…
- Scotland - United Kingdom FSS confirms enforcement of non-compliant products…
- Australia Labor party rejects recreational cannabis motion…
- South Dakota - United States Round two for recreational cannabis ballot…
- Oklahoma - United States Governor signs two medical cannabis-related bills…
- United States US FDA sends warning letters over CBD animal products…
- Paraguay COINCA confirms licence process for hemp…
- Australia Research looks at opportunities for growth in cannabis sector…
- Italy Vague decree on medical cannabis enters into force…
- Argentina Framework for hemp and medical cannabis in effect…
- Costa Rica Full regulation still awaited as licence requirement ends…
Business briefing
Current business and company-related news on the CBD industry
Regulatory briefing
Current legal and regulatory news covering the CBD industry
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market trackers
Up-to-date real-time information and insights on brands, pricing and retail across selected markets
Regulatory trackers
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
Charts and infographics
Highlights of the data and analysis that can be found in our full-length market reports
NEW FORMAT
From February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
Alerts
Our legal experts track the evolving regulation around the CBD and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
27th May 2022
- Japan: The Cannabis Control Review Subcommittee – set up by the Ministry of Health, Labour and Welfare to review drug control rules – is considering legalisation of medicinal products based on cannabis. However, it still considers introducing criminal penalties for cannabis use. Recreational cannabis is prohibited in Japan.
27th May 2022
- EU: New rules that "increase protection for EU consumers in several areas such as purchases through online marketplaces, transparency of price personalisation and ranking of online offers and consumer rights when using ‘free’ online services" will apply from tomorrow, 28th May 2022.
27th May 2022
- UK - Scotland: Asked about its approach to enforcement of novel food rules, Food Standards Scotland (FSS) told CBD-Intel that any businesses currently selling CBD products on the Scottish market are not in compliance with the novel food regulations and referred to the Food Standard Agency (FSA) list. "We are working closely with local authorities who have responsibility for the enforcement of non-compliant products," added the FSS representative.
27th May 2022
- Australia: A motion to decriminalise the possession of recreational cannabis introduced by the Legalise Cannabis Western Australia Party (LCWA) has been rejected by the ruling Labor Party, press reports. The motion would have allowed self-cultivation of up to two plants and possession of around 20 g of cannabis without penalty. Although the Labor Party decriminalised personal consumption of cannabis back in 2004, the Liberals later criminalised it. A Labor Party spokesperson from the government told the press that they "have no plans to legalise recreational cannabis".
27th May 2022
- US - South Dakota: A ballot measure to legalise recreational cannabis will again appear on the November ballot in South Dakota after officials certified enough signatures to qualify the measure, press reports. Voters passed a measure to legalise recreational cannabis in 2020 with 54% support, but that measure was later overturned by the South Dakota Supreme Court for violating the single-subject rule for ballot initiatives. The 2022 ballot initiative is authored by the same group, South Dakotans for Better Marijuana Laws, as the 2020 initiative but is stripped down to try to avoid violating the single-subject rule this time.
27th May 2022
- US - Oklahoma: House Bill (HB) 3929 and HB 2179 have been signed by the governor and enacted. HB 2179 establishes a licence fee schedule for medical cannabis cultivators, while HB 3929 establishes an optional process validation certification for medical cannabis laboratories.
27th May 2022
- US - Federal: The Food and Drug Administration (FDA) sent three warning letters on 26th May to companies who made health claims about CBD animal products. Letters to Hope Botanicals, Plantacea, and Haniel Concepts all cite health claims made by the CBD companies, but also share another common theme – they are warned against marketing CBD products as large animal and pet products. The FDA states that the CBD animal products "are unapproved new animal drugs that are unsafe under section 512(a) of the Federal Food, Drug, and Cosmetic Act".
27th May 2022
- Paraguay: The Interinstitutional Commission on Industrial Hemp (COINCA) told CBD-Intel that the licence to process the hemp plant in order to obtain non-psychoactive cannabinoids must be applied for according to the requirements set out in Resolution of the Ministry of Agriculture 155/2022. For the sale of hemp-derived products, in addition to complying with the requirements envisaged in Resolution of the Ministry of Industry and Commerce 1595/19, the interested party will be required to inform the Ministry of Agriculture and Livestock and the COINCA every month on the volume of hemp-derived products sold.
26th May 2022
- Australia: The Medicinal Cannabis Industry Australia (MCIA) has published a road map on the opportunities for the cannabis sector in the country. The document is a result of research conducted by the MCIA for the Victorian government Department of Jobs, Precincts, and Regions (DJPR), and it analyses the impact of the Victorian government’s Medical Cannabis Industry Development Plan (IDP). It sums up the current challenges and opportunities for growth of the sector.
26th May 2022
- Italy: The Decree on Officinal Plants entered into force last week and it subjects cannabis flower and leaf extraction intended for the production of medicinal products to the Narcotics Law. The text of the decree is vague and open to different interpretations; in fact, authorities might interpret it in a way that would ban the sale of hemp flowers and/or the extraction of hemp flowers and leaves. However, the Hemp Law has more authority than the decree, making it difficult for authorities to interpret the decree in these ways.
26th May 2022
- Argentina: The bill establishing a regulatory framework for medical cannabis and industrial hemp was published today (26th May) in the Official Gazette, entering into force. The government will now have 180 days to issue regulations that further develop the law, such as setting out the maximum allowed THC content in hemp. More detailed insights into the impact of said bill on Argentina’s legal framework can be found in our latest regulatory report.